Duraphat Lighter Fluoride Varnish is a Prescription Medicine.
1 mL suspension contains 50 mg sodium fluoride (5% w/v), equivalent to 22,600 ppm fluoride ion (22.6 mg of fluoride) in an alcoholic solution of natural resins.
Therapeutic indications: Caries prevention by deep penetration with fluoride. Desensitisation of sensitive teeth.
Contraindications: Hypersensitivity to any ingredients of Duraphat. Ulcerative gingivitis. Stomatitis. Bronchial asthma.
Special warnings and precautions for use. Application of Duraphat 50 mg/mL Dental Suspension to the whole dentition should not be carried out on an empty stomach. On the day when Duraphat has been applied, no high dose fluoride preparations, such as fluoride gels, should be used. The administration of fluoride supplements should be suspended for several days after applying Duraphat. Prolonged daily ingestion of excessive fluoride may result in varying degrees of fluorosis.
Interaction with other medicines and other forms of interaction: The presence of alcohol (33.8% v/v) in the Duraphat formula should be considered.
Fertility, pregnancy and lactation: As this product contains 33.8% v/v of ethanol (each dose contains up to 0.2 g of alcohol), it is recommended to avoid its use in pregnant women and during lactation.
Effects on ability to drive and use machines: None known.
Dose: Refer to datasheet for dosing and administration details.
For full information on dosage, contraindications, precautions, interactions and adverse effects please refer to the data sheet available at www.medsafe.govt.nz or by clicking on the link provided with this product. NZ Sponsor: Colgate-Palmolive Ltd, Lower Hutt, Wellington.
NP21457 - Aug 2024